Phase 4Recruiting
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity: A Pilot Study
- Sponsor
- Mayo Clinic (Academic or other)
- Enrolment
- 40 planned
- Conditions
- Obesity; Menopause Hot Flashes
- Interventions
- Tirzepatide; Placebo
- Ages
- adults
- Registry
- NCT07218445
From the registry
The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Primary outcomes
- Change in Vasomotor Symptoms Frequency
- Change in Vasomotor Symptom Severity
- Aging Biomarkers: Cellular Senescence Markers in Plasma
- Difference between biological and chronological age